FIELD: organic chemistry, biochemistry, medicine, pharmacy.
SUBSTANCE: invention relates to a compound and to all its enantiomeric and diastereomeric forms and pharmaceutically acceptable salts that are able to prevent extracellular release of inflammatory cytokines. Proposed compounds have the formula (I): wherein R represents: (a) -OR3 or (b) -NR4aR4b; R3 represents unsubstituted or substituted phenyl wherein substitutes are: (i) halogen atom; (ii) (C1-C6)-alkyl; (iii) trifluoromethyl; (iv) trichloromethyl; (v) tribromomethyl; (vi) cyano-group, and (vii) (C1-C6)-alkoxy-group; each R4a and Rb represents independently: (a) hydrogen atom or (b) -[C(R5aR5b)]xR6 wherein index x = 0-5; each R5a and R5b represents independently hydrogen atom, linear or branched (C1-C4)-alkyl, (C3-C7)-cyclic alkyl; R6 represents -OR7 or (C1-C4)-alkyl; R7 represents hydrogen atom or (C1-C4)-alkyl; R1 represents halogen-substituted phenyl; each among links R2a and R2b is chosen independently from the groups consisting of: (a) hydrogen atom; (b) -O(CH2)jR8; (c) -(CH2)jCO2R10; (d) -(CH2)jCON(R10)2; (e) a double bond when R2a and one R2b are chosen with formation of a double bond; (f) a ring when one R2a and one R2b are chosen with formation a ring and indicated ring is chosen from the group consisting of: (i) benzene and (ii) dioxalane; each R8 and R10 represents independently hydrogen atom or (C1-C4)-alkyl; j represents index from 0 to 5; m represents index from 1 to 3; n represents index from 1 to 3, and m + n = 4. Also, invention relates to a pharmaceutical composition based on abovementioned compounds that inhibits extracellular release of inflammatory cytokines, and a method for regulation of extracellular release of inflammatory cytokines.
EFFECT: valuable medicinal properties of compounds.
10 cl, 9 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
6,7-DIHYDRO-5H-PYRAZOLO[1,2-A]PYRAZOL-1-ONES REGULATING INFLAMMATORY CYTOKINES, (VARIANTS) AND PHARMACEUTICAL COMPOSITION | 2003 |
|
RU2289584C2 |
6,7-DIHYDRO-5H-PYRAZOLO[1,2-a]PYRAZOLE-1-ONES (VARIANTS) INHIBITING RELEASE OF INFLAMMATORY CYTOKINES, PHARMACEUTICAL COMPOSITION AND INHIBITION METHOD | 2002 |
|
RU2299885C2 |
SPIRO-6,7-DIHYDRO-5H-PYRAZOLO[1,2-a]PYRAZOLE-1-ONES THAT REGULATE INFLAMMATORY CYTOKINES, PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITION | 2002 |
|
RU2272040C2 |
COMPOUND BASED ON DIHYDRONAPTHYRIDINONE, METHOD OF ITS OBTAINING, AND ITS USE IN MEDICINE | 2021 |
|
RU2809869C1 |
FUSED PYRROLEDICARBOXAMIDES AND THEIR USE AS PHARMACEUTICALS | 2013 |
|
RU2650111C2 |
SUBSTITUTED 4-(ARYLAMINO) SELENOPHENOPYRIMIDINE COMPOUNDS AND METHODS OF THEREOF APPLICATION | 2011 |
|
RU2566293C2 |
CONDENSED TRIAZOLAMINES AS P2X7 MODULATORS | 2010 |
|
RU2533122C2 |
BICYCLIC HETEROCYCLIC DERIVATIVES, THEIR PRODUCTION AND APPLICATION | 2013 |
|
RU2627269C2 |
HETEROCYCLIC COMPOUNDS | 2005 |
|
RU2390522C2 |
DERIVATIVES OF CYCLOALKANOPYRIDINE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND INTERMEDIATE COMPOUNDS | 1997 |
|
RU2194698C2 |
Authors
Dates
2006-06-27—Published
2002-09-20—Filed